Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Journal of Biopharmaceutical Statistics|December 31, 2010
On power and sample size calculation in ethnic sensitivity studiesWei Zhang, Venkat SethuramanPharmaceutical Statistics|May 16, 2008
Impact of baseline ECG collection on the planning, analysis and interpretation of 'thorough' QT trialsVenkat Sethuraman, Qiankun SunJournal of Biopharmaceutical Statistics|February 13, 2009
Balanced 2(n) factorial designs when observations are spatially correlatedVenkat Sethuraman, Damaraju RaghavaraoJournal of Biopharmaceutical Statistics|April 2, 2010
Statistical consideration in testing for assay sensitivity in a "thorough" QT studyVenkat Sethuraman, Shuang Wu, Jixian WangJournal of Biopharmaceutical Statistics|March 18, 2017
Use of statistical and pharmacokinetic-pharmacodynamic modeling and simulation to improve decision-making: A section summary report of the trends and innovations in clinical trial statistics conferenceHolly Kimko, Seth Berry, Michael O'Kelly, et al.Therapeutic Innovation & Regulatory Science|August 21, 2019
Assessing Patient Participation Burden Based on Protocol Design CharacteristicsKenneth Getz, Venkat Sethuraman, Jessica Rine, et al.Therapeutic Innovation & Regulatory Science|December 10, 2020
Assessing Patient Participation Burden Based on Protocol Design CharacteristicsKenneth Getz, Venkat Sethuraman, Jessica Rine, et al.The Journal of Bone and Joint Surgery. American Volume|June 3, 2004
Comparison of transcranial electric motor and somatosensory evoked potential monitoring during cervical spine surgeryAlan S Hilibrand, Daniel M Schwartz, Venkat Sethuraman, et al.Journal of Biopharmaceutical Statistics|November 29, 2017
On evaluation of consistency in multi-regional clinical trialsLisa Ying, Fuyu Song, Shein-Chung Chow, et al.Journal of Clinical Pharmacology|August 13, 2010
Effects of rifampin and ketoconazole on the pharmacokinetics of nilotinib in healthy participantsChiaki Tanaka, Ophelia Q P Yin, Tom Smith, et al.Pageof 2